ATE269064T1 - Impfstoffe gegen den hepatitis b und c virus - Google Patents

Impfstoffe gegen den hepatitis b und c virus

Info

Publication number
ATE269064T1
ATE269064T1 AT95938824T AT95938824T ATE269064T1 AT E269064 T1 ATE269064 T1 AT E269064T1 AT 95938824 T AT95938824 T AT 95938824T AT 95938824 T AT95938824 T AT 95938824T AT E269064 T1 ATE269064 T1 AT E269064T1
Authority
AT
Austria
Prior art keywords
hepatitis
viral genome
virus
disclosed
incomplete
Prior art date
Application number
AT95938824T
Other languages
English (en)
Inventor
Catherine J Pachuk
Jack Wands
Takaji Wakita
Vincent R Zurawski Jr
Leslie R Coney
Katsutoshi Tokushige
Original Assignee
Apollon Inc
Massachusetts Gen Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26981379&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE269064(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Apollon Inc, Massachusetts Gen Hospital filed Critical Apollon Inc
Application granted granted Critical
Publication of ATE269064T1 publication Critical patent/ATE269064T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT95938824T 1994-10-05 1995-10-05 Impfstoffe gegen den hepatitis b und c virus ATE269064T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31824894A 1994-10-05 1994-10-05
US46785995A 1995-06-06 1995-06-06
PCT/US1995/013552 WO1996010997A1 (en) 1994-10-05 1995-10-05 Hepatitis virus vaccines

Publications (1)

Publication Number Publication Date
ATE269064T1 true ATE269064T1 (de) 2004-07-15

Family

ID=26981379

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95938824T ATE269064T1 (de) 1994-10-05 1995-10-05 Impfstoffe gegen den hepatitis b und c virus

Country Status (9)

Country Link
EP (1) EP0789563B8 (de)
JP (1) JPH11501204A (de)
AT (1) ATE269064T1 (de)
AU (1) AU701747B2 (de)
CA (1) CA2202088A1 (de)
DE (1) DE69533167D1 (de)
HU (1) HUT77870A (de)
NZ (1) NZ296304A (de)
WO (1) WO1996010997A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1009763A4 (de) * 1996-06-11 2002-08-07 Merck & Co Inc Synthetische hepatitis-c gene
JP2002125688A (ja) * 2000-10-30 2002-05-08 Tosoh Corp Ｃ型肝炎ウイルスの高感度検出のためのオリゴヌクレオチドおよび検出法
GB0226722D0 (en) * 2002-11-15 2002-12-24 Glaxo Group Ltd Vaccine
CU23496A1 (es) * 2004-09-03 2010-02-23 Ct Ingenieria Genetica Biotech Composición vacunal contra el virus de la hepatitis c

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0485209A1 (de) * 1990-11-08 1992-05-13 Immuno Japan Inc. Mit Non-A Non-B Hepatitis Virus verwandtes Antigen, Aufspürsysteme für Antikörper, Polynukleotide und Polypeptide
JPH0692996A (ja) * 1991-12-28 1994-04-05 Kunitada Shimotoono Ｃ型肝炎ウィルス粒子を構成する蛋白質およびその発現
DE69333269T2 (de) * 1992-01-31 2004-07-29 Abbott Laboratories, Abbott Park Expressionssystem in säugetieren für hcv-proteine
EP0625204B1 (de) * 1992-02-04 2002-06-19 Chiron Corporation Hepatistherapeutikum
JPH06141870A (ja) * 1992-03-12 1994-05-24 Tokyo Met Gov Rinshiyou Igaku Sogo Kenkyusho 非ａ非ｂ型肝炎ウイルス抗原をコードするｄｎａ断片
JPH06279500A (ja) * 1992-09-30 1994-10-04 Imuno Japan:Kk ＨＢｃ融合蛋白粒子およびその製造方法

Also Published As

Publication number Publication date
WO1996010997A1 (en) 1996-04-18
EP0789563A4 (de) 1998-10-07
EP0789563A1 (de) 1997-08-20
JPH11501204A (ja) 1999-02-02
AU701747B2 (en) 1999-02-04
DE69533167D1 (de) 2004-07-22
EP0789563B8 (de) 2004-11-17
EP0789563B1 (de) 2004-06-16
HUT77870A (hu) 1998-09-28
NZ296304A (en) 1999-06-29
AU4006195A (en) 1996-05-02
CA2202088A1 (en) 1996-04-18

Similar Documents

Publication Publication Date Title
CA2283464A1 (en) Functional dna clone for hepatitis c virus (hcv) and uses thereof
ATE335831T1 (de) Nukleinsäurevektor, einen solchen vektor enthaltene verbindung und impfstoff zur immunisierung gegen hepatitis
DK1187852T3 (da) Ekspression og eksport af interferon-alpha-proteiner som Fc-fusionsproteiner
DE69837708D1 (de) Von alphavirus abgeleitete vektoren als impfstoffe gegen eine paramyxovirusinfektion
ES2285832T3 (es) Complejo de peptido antigenico-proteina de choque termico modificada.
RU2003118436A (ru) Модифицированный вариант вируса коровьей оспы ankara
ATE309367T1 (de) Nukleotid- und aminosäuresequenzen der gene des hüllproteins 1 und des kernproteins von hepatitis c virus
EP1437400A3 (de) Künstliche Chromosome, die die genetische Information für die Bildung von rekombinantem rna-Virus enthalten
ATE269064T1 (de) Impfstoffe gegen den hepatitis b und c virus
Palese et al. Structure, Genetic structure and genetic variation of influenza viruses
DE69626681D1 (de) Konditionell-replizierende virale vektoren und ihre verwendung.
WO1996040764A3 (en) Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus
CU23245A1 (es) CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS
BR9908540A (pt) Molécula de ácido nucleico recombinante, célula hospedeira recombinante, composição farmacêutica, e, processo para induzir uma resposta imune contra vìrus de hepatite c em um humano não infectado por vìrus de hepatite c, para imunizar um humano suscetìvel a vìrus de hepatite c, e para tratar um humano que é infectado com vìrus de hepatite c
PT778894E (pt) Vacina da peritonite infecciosa felina.
WO1998023752A3 (de) Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen
HUP0103871A2 (hu) Rekombináns CELO-vírus és CELO vírus DNS
TH63069A (th) โคลนก่อการติดเชื้อ
RU97107000A (ru) Вакцины против вирусов гепатита
Morrison mRNA Vaccines and their impact on medicine.
FR2830019B1 (fr) Molecules d'acides nucleiques d'hdv, leurs fragments et leurs apllications
PT1254663E (pt) Agente antiviral
US20040001805A1 (en) Method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral DNA
Teichmann et al. Genome sequences and protein structures
CY1116971T1 (el) Ανοσογονες χιμαιρες δαγκειου ιου 2

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties